FDAFDA · Food and drugs·Recall number D-145-2013
Taztia XT(diltiazem HCI extended release capsules, USP, Once-A-Day Dosage, 360 mg, 90 Capsules per bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, Distributed by: Watson Pharma, NDC 62037-700-90.
Published February 13, 2013 · Recall initiated: December 18, 2012
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specification: Out of a specification result occurred during the 3-month stability testing. Dissolution result at the 4-hour time point was 41% (specification: 20-40%).
What to do
Voluntary: Firm initiated · E-Mail
Recall details
- Manufacturer
- Watson Pharmaceuticals
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot #: 512146A, Exp 01/31/2014
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.